AbbVie (ABBV) Assets Average (2013 - 2026)

AbbVie (ABBV) has reported Assets Average for 14 consecutive years, with $135.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average fell 0.65% year-over-year to $135.8 billion in Q2 2026; TTM through Jun 2026 was $135.8 billion, a 0.65% decrease from a year earlier, with the FY2025 full-year figure at $134.6 billion, changed 0.28% from the prior year.
• Assets Average was $135.8 billion for Q2 2026 at AbbVie, roughly flat from $135.2 billion in the prior quarter.
• Over five years, Assets Average peaked at $145.4 billion in Q2 2024 and troughed at $133.9 billion in Q4 2025.
• A 5-year average of $138.6 billion and a median of $136.7 billion in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average rose 7.74% in 2024 and decreased 6.01% in 2025, its largest moves.
• Over 5 years, Assets Average stood at $140.1 billion in 2022, then slipped by 3.28% to $135.5 billion in 2023, then advanced by 2.82% to $139.3 billion in 2024, then dropped by 3.85% to $133.9 billion in 2025, then climbed by 1.39% to $135.8 billion in 2026.
• The last three Assets Average figures came in at $135.8 billion (Q2 2026), $135.2 billion (Q1 2026), and $133.9 billion (Q4 2025), per Business Quant data.